Automated Cell Culture Systems Market: Overview
Automated cell culture systems have gained popularity for generating optimized cell lines across the entire spectrum ranging from seeding, feeding, passaging, to expansion of cells. They help meet strict standardization requirements, lowering contamination rates and minimizing human errors. Life sciences industries are harnessing automated systems for a wide spectrum of cell-based screening use in research and commercial applications. Demand in the automated cell culture systems market stems from the expanding the use of high-throughput cell lines in drug discovery research.
Read Report Overview -
https://www.transparencymarketresearch.com/automated-cell-culture-systems-market.html
Automated cell culture helps in the production of large volumes and high-quality cell lines for drug research, rendering high safety and product efficacy. Other key research applications in the market are interference RNA (RNAi), cell-based drug transport, metabolism, and toxicology studies.
The report offers an in-depth insights into key growth dynamics, regulatory landscape, new avenues, and revenues in key applications. The assessments strive to take a closer look at the automation trends and key winning imperatives that may heavily influence the competitive dynamics in coming years.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79115
Automated Cell Culture Systems Market: Key Trends
Human pluripotent stem cell studies hold vast potential in modelling human diseases. Strides in the automated cell culture systems market have made this possible, and offer significant advantages over the manual ones. The growing popularity of personalized regenerative or cell replacement therapies is a key trend. Rapidly growing number of stem cell–based studies in developing and developed countries has imparted a robust fillip to the expansion in the automated cell culture systems market. Over the years, with personalized regenerative medicine gathering traction among life science research companies, new avenues have emerged.
Advances being made in structural biology have also spurred growth of the automated cell culture systems market.
Request for Analysis of COVID-19 Impact on Automated Cell Culture Systems Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79115
Automated Cell Culture Systems Market: Competitive Analysis and Key Developments
Adoption of human iPSC lines in the generation of human iPSC lines has opened a new avenue in the automated cell culture systems market. They are benefitting from the development, manufacturing and customization of precision measurement devices. The generation of biobanks of iPSCs is a key trend in the automated cell culture systems market in developed regions, and is a key factor spurring industry collaborations of various types.
A case in point is when The California Institute for Regenerative Medicine (CIRM) collaborating with Cellular Dynamics International, Inc. (CDI) in the U.S. planned to generate 9000 iPSC lines from 3000 individuals. A number of consortiums have cropped up to this end. An example is The European Bank for induced pluripotent Stem Cells (EBiSC). Induced pluripotent stem cells cater to a wide range of diseases. Another example is the AUTOSTEM Consortium using automated cell culture systems for developing patient-specific iPSCs for ophthalmic research. Expanding the cell line in this manner will boost clinical trials for various diseases. Patients with ischemic strokes are likely to benefit from the clinical trials in Phase II from the adoption of automated cell culture system in CTX0E03 cell line.
Key industry players thriving in the automated cell culture systems market are Lonza Group Ltd., Merck KGaA, Promocell GmbH, and Hamilton Medical AG.
Pre Book Automated Cell Culture Systems Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=79115<ype=S
Automated Cell Culture Systems Market: Regional Assessment
Regionally, North America has been presenting substantial revenue streams for manufacturers of automated cell culture systems. The healthcare system in developed parts of the region has seen personalized regenerative or cell replacement therapies gathering immense traction. Stakeholders in the region are leaning on the extensive application of automated stem cell culture in stem cell studies. The regional market has seen players constantly focusing on investing to expand the capacities of automated cell culture systems. The regional market has also benefitted from the increasing trend of modernization of stem cell biology.
More Trending Reports by Transparency Market Research –
Dental Imaging Market:
Alpha Mannosidosis Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
